Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vedat Hamuryudan

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Ocular Immunology and Inflammation|July 30, 2024
Development of Posterior Uveitis in Behçet Syndrome Patients with Vitreous Cells at BaselineDidar Ucar, Basak Ecem Bircan, Nigar Rustamli, et al.
Clinical and Experimental Rheumatology|March 15, 2024
Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitionsMustafa Erdogan, Burcak Kilickiran Avci, Cansu Ebren, et al.
Rheumatology (Oxford, England)|September 11, 2019
Clinical course of acute deep vein thrombosis of the legs in Behçet's syndromeYesim Ozguler, Gulen Hatemi, Firat Cetinkaya, et al.
Rheumatology (Oxford, England)|December 10, 2009
Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trialVedat Hamuryudan, Gulen Hatemi, Koray Tascilar, et al.
Seminars in Arthritis and Rheumatism|December 6, 2014
An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet's syndrome followed up at a single, dedicated centerEmire Seyahi, Erkan Caglar, Serdal Ugurlu, et al.
Rheumatology (Oxford, England)|May 11, 2024
Validation of the Behçet's Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modificationYeliz Yagiz Ozogul, Yesim Ozguler, Sinem N Esatoglu, et al.
Rheumatology International|October 5, 2016
Re-initiation of biologics after the development of tuberculosis under anti-TNF therapyYesim Ozguler, Gulen Hatemi, Serdal Ugurlu, et al.
The Journal of Rheumatology|February 18, 2014
Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trialVedat Hamuryudan, Gulen Hatemi, Koray Tascilar, et al.
Rheumatology International|March 10, 2015
Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in TurkeyNurullah Akkoç, Haner Direskeneli, Hakan Erdem, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiationGul Guzelant, Didar Ucar, Sinem Nihal Esatoglu, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Ocular Immunology and Inflammation|July 30, 2024
Development of Posterior Uveitis in Behçet Syndrome Patients with Vitreous Cells at BaselineDidar Ucar, Basak Ecem Bircan, Nigar Rustamli, et al.
Clinical and Experimental Rheumatology|March 15, 2024
Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitionsMustafa Erdogan, Burcak Kilickiran Avci, Cansu Ebren, et al.
Rheumatology (Oxford, England)|September 11, 2019
Clinical course of acute deep vein thrombosis of the legs in Behçet's syndromeYesim Ozguler, Gulen Hatemi, Firat Cetinkaya, et al.
Rheumatology (Oxford, England)|December 10, 2009
Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trialVedat Hamuryudan, Gulen Hatemi, Koray Tascilar, et al.
Seminars in Arthritis and Rheumatism|December 6, 2014
An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet's syndrome followed up at a single, dedicated centerEmire Seyahi, Erkan Caglar, Serdal Ugurlu, et al.
Rheumatology (Oxford, England)|May 11, 2024
Validation of the Behçet's Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modificationYeliz Yagiz Ozogul, Yesim Ozguler, Sinem N Esatoglu, et al.
Rheumatology International|October 5, 2016
Re-initiation of biologics after the development of tuberculosis under anti-TNF therapyYesim Ozguler, Gulen Hatemi, Serdal Ugurlu, et al.
The Journal of Rheumatology|February 18, 2014
Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trialVedat Hamuryudan, Gulen Hatemi, Koray Tascilar, et al.
Rheumatology International|March 10, 2015
Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in TurkeyNurullah Akkoç, Haner Direskeneli, Hakan Erdem, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiationGul Guzelant, Didar Ucar, Sinem Nihal Esatoglu, et al.
Pageof 9